Clinical trials would need to assess both hemodynamic parameters and clinical outcomes including walking distance, pain scores, and amputation rates to establish therapeutic benefit
Furthermore, advancements in formulation technologies, such as the application of nanocarriers and sustained-release and controlled-release technologies, may enhance the bioavailability and efficacy of BPC 157, providing more possibilities for its clinical application
Taken together, these data demonstrate complex synergistic interaction between the beneficial activity of NaBPC157 and peptidergic sensory afferent neuron activity
It is not FDA-approved for treating any condition
Functional imaging studies indicate that activity within the right superior and inferior parietal lobes is increased during performance of working memory tasks in untreated women with PCOS
Injectable peptides should ideally be obtained through compounding pharmacies with medical oversight